ECTS
120 credits
Duration
2 years
Training structure
School of Pharmacy, School of Science
Language(s) of instruction
French
Presentation
The IBIS program in Therapeutic Engineering and Bioproduction in Health Biotechnology (Red Biotechnology) within the Biology and Health major is designed to train students to create and produce the therapies of tomorrow using biotechnology tools. Scientific advances in understanding human diseases are leading to innovations in health, most of which are driven by biotechnology companies. The dynamism in France and around the world in the creation of highly specialized companies with specific expertise must be matched by developments in training programs leading to these new professions and skills.
These therapies are complex in nature and use.
therapeutic applications, and obtaining them will therefore require multidisciplinary and cross-functional skills in biotechnology, which the IBIS program aims to address. The IBIS program is based on the needs of manufacturers in the sector, which are identified in the report by Leem (the professional organization for pharmaceutical companies) entitled "Skills Plan, Biotech/Innovations, Health 2020."
The aspects developed concern:
- Biotechnological tools designed to discover innovative therapeutic molecules, whether biological (recombinant proteins and antibodies, cells) or chemical in nature.
- The engineering of bioprocesses for the industrial production of these compounds will also be developed, as will their formulation and vectorization (nanobiotechnologies).
In addition, an introduction to agro-environmental (green and yellow), marine (blue), and industrial (white) biotechnologies will be offered through cross-disciplinary teaching units with other master's programs. Furthermore, an agreement is planned with Polytech Montpellier to offer a dual training program validated by a dual Engineering/Master's degree:
- Two students from Polytech Montpellier per year, Biological and Food Engineering (GBA), to enter the health biotechnology sector (pharmaceuticals, cosmetics, etc.)
- to two students from the Master's in Biology-Health/IBIS program per year, to enter the agri-food and nutrition sector.
In summary, the IBIS program is an innovative training course in the field of health biotechnology, designed to meet the needs of industry professionals by offering applied, multidisciplinary, practical, and integrated teaching for science students, pharmacists, engineers, and those in continuing education.
The advantages of the training program
Innovative teaching methods
The IBIS program will place significant emphasis on innovative teaching methods, particularly through project-based learning and real-life scenarios for students (fictional projects, experimental projects, etc.). In this context, students will have access to Learning Labs and bioproduction equipment on an R&D pilot scale. In addition to mobilizing, consolidating, and building students' knowledge, this teaching approach will prepare them for their future careers, which require adaptability, creativity, teamwork, versatility, initiative, and curiosity.
Learning English is essential in the IBIS curriculum and is clearly identified by a dedicated course unit in the second semester of the Master 1 program. In addition, several course units and projects will be conducted entirely in English.
PARTNERSHIP
A partnership has been established with Polytech Montpellier tooffer a dual Engineering/Master's degree to two students per year from Polytech Montpellier's Biological and Food Engineering (GBA) program in the biotechnology and health sector (pharmaceuticals, cosmetics, etc.). Conversely, two students from the Biology-Health/IBIS Master's program will also be able to access engineering training in the field of agri-food and nutrition.
The IBIS educational project is supported by Labex Mablmprove (dedicated to improving therapeutic antibodies) for certain teaching units. This Labex aims to develop training in the field of therapeutic antibodies at the national level. It will also enable IBIS students to access internships in the field, with remuneration covered by LabEx, which also plans to fund Cifre theses with companies focused on therapeutic antibodies.
Anexchange program with Worcester Polytechnic Institute (WPI, MA, USA, https://www.wpi.edu/) has also been established. This agreement will enable two students to undertake an internship in biotechnology or bioinformatics in one of the host laboratories.
Theacademic research structures to whichthe teacher-researchers are attached could be potential locations for IBIS students' M1 internships. These structures belong to various clusters such as the Rabelais Biology-Health cluster (IRCM, IRMB, INM, IGH, IGF), the BALARD Chemistry cluster (ICGM, IBMM) and the Agropolis International cluster (IATE, Qualisud).
IBIS students will have access to theEMBnet network (The Global Bioinformatics Network), which brings together laboratories and companies in the field of bioinformatics.
We will also be able to draw on an industrial network bothfrom an educational perspective (presentations by professionals, site visits, etc.) and from a professional integration perspective (internships, professional training contracts, future employers). Some examples of partner companies: Deinove, Protéus, LFB, Sanofi, Servier, SATT, Cisbio, etc.
Objectives
Upon completion of the IBI program, students will have mastered all the concepts necessary to create, produce, formulate, and modify biotechnology-based therapies with a view to providing personalized treatment for patients. The concepts acquired will be applicable to health biotechnology as well as other areas of biotechnology (nutrition, cosmetology, agro-environment, etc.)..
Know-how and skills
Scientific knowledge
- -omic strategies
- High-throughput screening, drug design
- Obtaining and engineering biopharmaceuticals
- Immunotherapy and monoclonal antibodies
- Bioinformatics and systems biology
- Bioproduction strategy
- Cell banks
- Process engineering
- Physical chemistry, biochemistry, analytical chemistry
- Development and monitoring of bioprocesses (planning, scheduling, improvement of industrial performance)
- Biopharmacy, nanobiotechnology
- Life sciences engineering (e.g., genetic and protein engineering)
Soft Skills
- Multi/interdisciplinarity
- Cross-functional approach
- Project and team management
- Spoken and written English
Environmental knowledge
- Industrial property
- Risk management (biological and financial)
- Scientific and technological monitoring
- Ethics and regulations
Organization
Program
This program is jointly run by the Science and Pharmacy departments, offering students multidisciplinary training at the intersection of pharmaceutical, biological, and engineering sciences.
The M1, a common foundation of knowledge in biotechnology and health:
The M1 is designed to provide students with a common foundation of knowledge in biotechnology, regardless of their previous training. In line with a multidisciplinary and cross-disciplinary approach, the courses are dedicated to engineering sciences: functional genomics, statistics applied to biology, bioinformatics, immunotechnology, and bioprocess engineering. A significant portion of the program is also devoted to professional development, with courses in scientific English and communication, and a long internship (minimum duration of 4 to 5 months).
The M2, a common foundation in innovation management, followed by a specialization in Therapeutic Engineering or Bioproduction, open to apprenticeships:
The M2 program is divided into two semesters:
- a core curriculum (10 ECTS) covering intellectual property, innovation management and financing, bioethics, and project and risk management, with three teaching units (UE);
- and two specialized blocks (20 ECTS) of the student's choice, allowing them to progressively specialize in Therapeutic Engineering or Bioproduction.
The specialization in biotherapeutic engineering is divided into five course units: Discovery of New Drugs, Biotherapy Engineering, Formulation of Biopharmaceuticals and Biomaterials, Nanotechnologies for Health, and Multidisciplinary Lab Project.
The specialization in bioproduction is divided into five teaching units: Bioprocess Engineering (continuous and fed-batch; specificities of health applications; recombinant protein production), Bioproduction and Valorization of Microbial Biodiversity, and Multidisciplinary Lab Project.
Openness to learning:
The M2 is open to learning. Three periods of classes are identified. In the traditional format, these are interspersed with project periods, a long-term internship, and breaks; in the work-study format, they are interspersed with periods spent in companies and breaks. Regardless of the M2 format chosen by the student, the second semester is entirely devoted to a long-term internship, preferably in an industrial setting, in order to promote the professional integration of students at their internship/apprenticeship location.
Teaching methods incorporating innovative pedagogy:
The IBIS program places great importance on innovative teaching methods, focusingin particular on project-based learning and real-life scenarios for students (experimental projects, etc.). This approach makes it possible to "improve student motivation, venture beyond disciplines, and thus mobilize students' cross-disciplinary skills, familiarize students with the complexity of today's professional world, while helping them to build a personal and professional project as they progress through their studies."(Reverdy Catherine 2013 "Project-based learning: from research," Technology, Science, and Industrial Techniques journal https://eduscol.education.fr/sti/sites/eduscol.education.fr.sti/filles/ressources/techniques/5180/5180-186-p46.pdf.
In addition to mobilizing, consolidating, and building students' knowledge, this teaching method will prepare them for their future careers, which require adaptability, creativity, teamwork, versatility, initiative, and curiosity.
These innovative teaching methods are introduced in the first year of the master's program and become a key part of the second year, particularly with the multidisciplinary lab projects, which represent 5 to 9 ECTS credits depending on the chosen specialization. This multidisciplinary project runs throughout the semester, with several weeks set aside for intensive study. It is conducted entirely in English and based on learning by doing. It will enable students to develop their professional skills: knowledge, but also know-how and interpersonal skills (teamwork, multidisciplinary work, project management, etc.). The first part takes place in the Learning Lab (funded by the AAP Muse Take-Off 1§2), and the second part is carried out in practical work rooms on pilot-scale equipment. In this context, students will be required to carry out an R&D project, such as setting up recombinant protein production. Students will be responsible for all stages: from genetic construction and obtaining the producing strain to pilot-scale production and protein purification.
Students operate on a project management basis. This project-based working method is essential for future executives, such as IBIS students, to understand.
Select a program
Master 1 IBIS Therapeutic Engineering and Bioproduction in Biotechnology-Health
Master 1 IBIS Therapeutic Engineering and Bioproduction in Biotechnology-Health
Experimental models in biomedical research
5 creditsProtein engineering
5 creditsStatistics applied to biology
5 creditsBioinformatics and Antibody Bioinformatics
5 creditsImmunotechnology (PHARMACY EU)
5 credits
Master 2 IBIS Therapeutic Engineering and Bioproduction in Biotechnology-Health
Master 2 IBIS Therapeutic Engineering and Bioproduction in Biotechnology-Health
Bioproduction and valorization of microbial biodiversity
3 creditsRecombinant protein production engineering
3 creditsMultidisciplinary Lab Project 1 (Pharmacy Unit)
3 creditsBioethics and regulation (EU PHARMACY)
3 creditsBioprocess Engineering II, Specific Applications
2 creditsPromoting research and innovation
5 creditsContinuous and fed-batch bioprocess engineering
3 creditsProject management and risk management
Multidisciplinary Lab Project 2
6 credits
Long internship_FDS
30 credits
M2 IBIS Therapeutic Engineering and Bioproduction in Biotechnology-Health LEARNING
Bioproduction and valorization of microbial biodiversity
3 creditsRecombinant protein production engineering
3 creditsMultidisciplinary Lab Project 1 (Pharmacy Unit)
3 creditsBioethics and regulation (EU PHARMACY)
3 creditsBioprocess Engineering II, Specific Applications
2 creditsPromoting research and innovation
5 creditsContinuous and fed-batch bioprocess engineering
3 creditsProject management and risk management
Multidisciplinary Lab Project 2
6 credits
Long internship_FDS
30 credits
Admission
Registration procedures
Applications for M1 programs are submitted on the following platforms:
- French and European students: follow the "Mon Master" procedure on the website: https://www.monmaster.gouv.fr/
- International students from outside the EU: follow the "Études en France" procedure: https://pastel.diplomatie.gouv.fr/etudesenfrance/dyn/public/authentification/login.html
Target audience
The program is open to M1-level students in science, technology, and health from:
- L3 Life Sciences
- L3 Science and Technology
- L3 CMI (Master's Degree in Engineering) Biotechnology
- Pharmacist DFASP1 in research.
Other students who have not necessarily studied biology (e.g., L3 Chemistry) may also be admitted to the program, depending on their academic record and possibly after completing a refresher course (MOOC, etc.).
Direct admission to the second year of the master's program will also be possible for a limited number of students from other first-year biology and health programs, health programs (pharmacists, doctors, interns), or engineering programs (partnership with Polytech Montpellier, Biological and Food Engineering).
Mandatory prerequisites
Bachelor's degree (or equivalent) with a foundation in (bio)chemistry, molecular biology, genetics, cell biology, microbiology, and immunology.
Recommended prerequisites
Prior training in biotechnology is an added bonus.
And after
Continuing education
Students may, if they wish, continue their studies in a doctoral program in an academic or industrial setting.
Other students also have the opportunity to specialize in project management by enrolling in management schools.
Professional integration
The main target sector is the pharmaceutical and biotechnology sector, whether within:
- Biotechnology companies
- Pharmaceutical and veterinary industries
- CRO (Contract Research Organization) and CMO (Contract Manufacturing Organization)
- Consulting firms
- Public research organizations (CNRS, Inserm, universities, etc.)
- University Hospital
- Partnership and promotion service (Technology Transfer and Acceleration Companies (SATT), Inserm Transfert, etc.)
- Competitiveness clusters
- Incubators in the field of biotechnology
with the following professions:
- Biotechnology Project Manager
- Pharmaceutical R&D Engineer
- Pharmacist in charge in the pharmaceutical industry
- Bioproduction Project Manager
- Process Development Engineer
- Drug delivery systems engineer
- Research engineer in a public laboratory or on a platform
- SATT maturation engineer
- Business Manager in Biotechnology Transfer
- Industrial property attorney